Cargando…
Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
BACKGROUND/AIMS: Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to sprue-like enteropathy. No cases of olmesartan-associated enteropathy have been reported in Northeast Asia. We investigated the associations between olmesartan and other ARBs and the incidence of ent...
Autores principales: | You, Seng Chan, Park, Hojun, Yoon, Dukyong, Park, Sooyoung, Joung, Boyoung, Park, Rae Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325440/ https://www.ncbi.nlm.nih.gov/pubmed/29172402 http://dx.doi.org/10.3904/kjim.2017.002 |
Ejemplares similares
-
Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015) -
Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016) -
Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017) -
Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016) -
A Case Report of Olmesartan-Induced Enteropathy
por: Daines, Benjamin S, et al.
Publicado: (2021)